Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

2 of 2 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07118358Not ApplicableNot Yet Recruiting

BIOTRONIK Investigation of the LivIQ Leadless Pacemaker System

Role: collaborator

NCT06840509Not ApplicableActive Not Recruiting

BIO|CONCEPT.CorSky, First in Human Study for the CorSky ICD Family

Role: lead

NCT05610176Not ApplicableCompleted

BIO|CONCEPT.Amvia Study

Role: lead

NCT04683718Not ApplicableActive Not Recruiting

A First in Human Feasibility Study to Evaluate the Safety and Effectiveness of the BIOTRONIK Prospera SCS System with HomeStream Remote Management

Role: collaborator

NCT04350008Completed

BIO|CONCEPT.Renamic Neo Study

Role: lead

All 5 trials loaded